News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Steven K. Schelhammer Elected to BioScrip Board
May 23, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
ELMSFORD, N.Y.--(BUSINESS WIRE)--BioScrip, Inc. (NASDAQ: BIOS) announced today that Mr. Steven K. Schelhammer had been elected to BioScrip’s Board of Directors at the Company’s annual meeting of stockholders.
Twitter
LinkedIn
Facebook
Email
Print
People
MORE ON THIS TOPIC
Venture capital
New biotech Setara forms with $90M to take on Jazz’s bonus rare disease programs
October 30, 2026
·
1 min read
·
Annalee Armstrong
Drug Development
Dren Bio lands $350M to push rare blood cancer therapy toward market
October 29, 2026
·
2 min read
·
Gabrielle Masson
Earnings
Lilly’s guidance has jumped by $10B as GLP-1 sales keep blowing past expectations
October 29, 2026
·
3 min read
·
Annalee Armstrong
Earnings
Merck looks ahead to ‘another year of investment’ as Keytruda cliff looms
October 29, 2026
·
4 min read
·
Heather McKenzie
